Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2266

Actual shortage: 50 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 19 (1%)
Resolved: 2197 (97%)

Discontinuation Reports

124

To be discontinued: 4 (3%)
Discontinued: 118 (95%)
Reversed: 2 (2%)

Late reports

451 (19%)

Overdue reports

13 (24%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-27 2023-03-02 182582
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-02 2023-03-21 186077
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-04 2023-05-03 188668
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-18 2023-05-03 189801
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-08 2023-06-20 192018
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-15 2023-05-25 192570
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-10 2023-08-01 197996
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-24 2023-08-01 199832
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-25 2024-01-18 205156
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-10 2023-10-31 206701
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-17 2025-05-21 216208
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-21 2024-11-19 228441
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-21 2024-11-05 228446
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-13 2025-03-04 247623
SANDOZ TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2025-06-16 2025-07-01 260357
SANDOZ TELMISARTAN 40MG TABLET Resolved 2017-03-14 2017-05-08 2657
SANDOZ TELMISARTAN 40MG TABLET Resolved 2017-05-15 2017-06-13 10317
SANDOZ TELMISARTAN 40MG TABLET Resolved 2017-06-26 2017-09-07 13941
SANDOZ TELMISARTAN 40MG TABLET Resolved 2018-10-15 2018-10-29 64138
SANDOZ TELMISARTAN 40MG TABLET Resolved 2018-10-15 2018-11-27 64153

Showing 1921 to 1940 of 2266

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 124